Tempus xT Heme
648-gene DNA sequencing configuration for hematologic neoplasms.
- Developer
- Tempus AI
- Intended use
- Other
- Cancer scope
- Hematologic neoplasms
- Specimen
- Bone marrow aspirate, FFPE tumor tissue, Peripheral whole blood
- Molecular modality
- DNA mutation
- Current version
- Current Tempus xT Heme 648-gene DNA-sequencing configuration (2026-09)
- Evidence context
- 0 structured studies · 0 indexed performance results · 1 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.